Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing

Lupus · Published 2026-07-31 · DOI 10.1177/09612033261473968

Free full text

Authors (7)

Matthew Wong, Muhammad Akram, Joanna R. Kent, Peter J. Fuller, Alberta Hoi, Jun Yang, Fabien B. Vincent

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wong, M., Akram, M., Kent, J., et al. (2026). Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing. Lupus. https://doi.org/10.1177/09612033261473968

Related articles

• Unusual triad in systemic lupus erythematosus: Alopecia, pigmentation, and keratoderma · Lupus · 2026 · Same journal
• Continuation of belimumab in patients with systemic lupus erythematosus in a real-world setting: A single-center retrospective cohort study · Lupus · 2026 · Same journal
• Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022–2025) · Lupus · 2026 · Same journal
• Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus · Lupus · 2026 · Same journal
• Frequency and clinical associations of Epstein-Barr virus molecular detection in systemic lupus erythematosus: A follow-up study · Lupus · 2026 · Same journal
• Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus · Lupus · 2026 · Same journal
• Linear/arciform blaschkoid lupus erythematosus tumidus of the face – An extremely rare clinical manifestation · Lupus · 2026 · Same journal
• Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort · Lupus · 2026 · Same journal
• Long-term outcomes of patients with moderate-severe pediatric systemic lupus erythematosus treated with combination rituximab and cyclophosphamide therapy: A single center cohort experience and review of literature · Lupus · 2026 · Same journal
• Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state · Lupus · 2026 · Same journal